Clifford Swan Investment Counsel’s St Jude Medical STJ Stock Holding History

Clifford Swan Investment Counsel’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,353	Closed	-$349K	–	300
2016 Q4	$349K	Sell	4,353 -1,050	-19%	-$83.3K	0.02%	222
2016 Q3	$431K	Sell	5,403 -2,030	-27%	-$164K	0.03%	206
2016 Q2	$580K	Buy	+7,433	New	+$530K	0.04%	177

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Clifford Swan Investment Counsel's STJ Position: Q1 2017 in Review

Clifford Swan Investment Counsel sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,353 shares — an estimated $349K sold.

Clifford Swan Investment Counsel first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $580K in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Clifford Swan Investment Counsel reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Clifford Swan Investment Counsel sold 4,353 St Jude Medical shares in Q1 2017, an estimated $349K.
Clifford Swan Investment Counsel first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
Clifford Swan Investment Counsel's St Jude Medical position peaked at $580K in Q2 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Clifford Swan Investment Counsel's 13F filing for Q1 2017, filed 9 May 2017.